Recombinant Anti-CLCN7 Vesicular Antibody, EV Displayed (VS-0425-YC536) (CAT#: VS-0425-YC536)

The Recombinant Anti-CLCN7 Vesicular Antibody, EV Displayed (VS-0425-YC536) is an antibody-displaying extracellular vesicle (Ab-EV). The product combines the benefits of both extracellular vesicle (EV) and antibody (Ab) which can guide the decorated EVs to CLCN7-expressed cells or tissues. CLCN7 belongs to the CLC chloride channel family, important in bone resorption. Mutations in CLCN7 cause osteopetrosis, presenting with overly dense bone due to defective resorption. Both recessive and dominant forms of osteopetrosis are associated with this protein.

Specific Inquiry
  • Datasheet
  • MSDS
  • COA

Recombinant Antibody

  • Application
  • ELISA, FC, Cell-uptake
  • Product Type
  • Ab-Fc-EVs
  • Antibody Quantification (Ab/EV)
  • ~100 Ab/EV
  • Target
  • CLCN7
  • Host Animal
  • Mouse
  • Antibody Isotype
  • IgG
  • Species Reactivity
  • Human
  • Expression Cell
  • Mammalian cell

Engineered EVs

  • EV-sorting domain
  • CD63
  • Fc-binding domain
  • Protein A
  • EV Size
  • 30~150 nm
  • Producing Cell
  • HEK293F
  • Isolation Method
  • Gradient centrifugation
  • Purification
  • qEV size exclusion chromatography
  • Concentration
  • 1 x 10¹⁰
  • Size
  • 1 mL
  • Buffer
  • PBS
  • Storage
  • Store at -80°C for 12 months

Target

  • Full Name
  • Chloride voltage-gated channel 7
  • Biological Process
  • Antiport, Ion transport, Transport
  • Introduction
  • The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood.
  • Alternative Names
  • CLC-7, CLC7, OPTA2, PPP1R63

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CLCN7"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibodies Fab Antibodies ScFv Antibodies

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0425-YC536. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare